End-of-day quote
Other stock markets
|
||
- EUR | - |
May. 02 | QIAGEN Announces the Availability of QCI Secondary Analysis | CI |
Apr. 30 | QIAGEN NV : Berenberg reaffirms its Buy rating | ZD |
Sales 2024 * | 2.01B 1.87B | Sales 2025 * | 2.14B 1.99B | Capitalization | 9.53B 8.87B |
---|---|---|---|---|---|
Net income 2024 * | 404M 376M | Net income 2025 * | 450M 419M | EV / Sales 2024 * | 4.91 x |
Net Debt 2024 * | 325M 302M | Net cash position 2025 * | 206M 192M | EV / Sales 2025 * | 4.36 x |
P/E ratio 2024 * |
23.6
x | P/E ratio 2025 * |
21.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.67% |
Latest transcript on Qiagen NV
Managers | Title | Age | Since |
---|---|---|---|
Thierry Bernard
CEO | Chief Executive Officer | 60 | 15-01-31 |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Roland Sackers
DFI | Director of Finance/CFO | 56 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 11-05-31 | |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Lawrence Rosen
CHM | Chairman | 66 | 13-06-25 |
1st Jan change | Capi. | |
---|---|---|
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |